James Greg Murison

Title: James Greg Murison: Innovator in Immunology

Introduction

James Greg Murison is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of immunology through his innovative research and patented technologies. With a total of 2 patents, Murison's work focuses on enhancing immune responses and developing novel polynucleotides and polypeptides.

Latest Patents

Murison's latest patents include methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides. These patents provide isolated polynucleotides and polypeptides derived from mammalian fsn -/- lymph node stromal cells, along with expression vectors and host cells that comprise such isolated polynucleotides. Additionally, he has developed methods for the use of these polynucleotides and polypeptides, which include novel polynucleotides with partial and extended sequences, open reading frames, probes, primers, and DNA constructs. His work also encompasses biological materials and organisms that incorporate these polynucleotides and polypeptides, along with methods for their application.

Career Highlights

James Greg Murison is associated with Genesis Research & Development Corporation Limited, where he continues to advance his research in immunology. His career is marked by a commitment to innovation and the development of new technologies that can have a significant impact on health and medicine.

Collaborations

Throughout his career, Murison has collaborated with esteemed colleagues, including Nevin Abernethy and James Douglas Watson. These collaborations have further enriched his research and contributed to the advancement of his patented technologies.

Conclusion

James Greg Murison is a distinguished inventor whose work in immunology has led to valuable patents and advancements in the field. His contributions continue to influence research and development in enhancing immune responses.